DAVID KRUKIEL: Open Payments
NPI 1184207680 · RICHMOND, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,705 in 89 payments from 15 companies in 2025. Trend: 2023 $1,630 · 2024 $1,327 · 2025 $1,705
Food & beverage: $1,705
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $370 |
| Otsuka America Pharmaceutical, Inc. | 13 | $313 |
| Vanda Pharmaceuticals Inc. | 12 | $200 |
| Lundbeck LLC | 10 | $159 |
| Neurocrine BioSciences, Inc. | 5 | $125 |
| Janssen Pharmaceuticals, Inc | 4 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $84 |
| HARMONY BIOSCIENCES LLC | 2 | $74 |
| ABBVIE INC. | 4 | $60 |
| Supernus Pharmaceuticals, Inc. | 3 | $50 |
Products named: REXULTI, CAPLYTA, INGREZZA, SPRAVATO, HETLIOZ, FANAPT, TRINTELLIX, WAKIX.
Industry payments across VA — which companies pay providers there.
